Tumor PIK3CA mutations, lymphosyte infiltration and recurrence-free survival (RFS) in early breast cancer (BC): Results from the FinHer Trial
- S Loi (Speaker)
- S Michiels (Speaker)
- D Lambrechts (Speaker)
- R Saldago (Speaker)
- N Sirtaine (Speaker)
- D Fumagalli (Speaker)
- B Claes (Speaker)
- kellokumpu-Lehtinen, P. (Speaker)
- P Bono (Speaker)
- V Kataja (Speaker)
- D Larsimont (Speaker)
- P Piccart-Gebhart (Speaker)
- H Joensuu (Speaker)
- C Sotiriou (Speaker)
Activity: Talk or presentation › Conference presentation